par Hontebeyrie, Mireille;Truyens, Carine
;Brenière, Simone Frédérique Rédérique S.F.
Editeur scientifique Telleria, Jenny;Tibayrenc, Michel
Référence American Trypanosomiasis - Chagas Disease - One Hundred Years of Research, Elsevier, London
Publication Publié, 2010
;Brenière, Simone Frédérique Rédérique S.F.Editeur scientifique Telleria, Jenny;Tibayrenc, Michel
Référence American Trypanosomiasis - Chagas Disease - One Hundred Years of Research, Elsevier, London
Publication Publié, 2010
Partie d'ouvrage collectif
| Résumé : | The most severe pathology induced by Trypanosoma cruzi concerns the heart disease that affects 2030% of the infected patients and leads to sudden death. Only 510% suffer from megaesophagus, megacolon, or peripheral neuropathies. The pathophysiology of Chagas heart disease is still not totally understood and two main mechanisms have been proposed: (i) parasite-dependent myocardial damage and (ii) impaired immunological responses associated to molecular mimicry (epitope common between host and parasite molecules) (for review see Marin-Neto et al., 2007). If the clinical features were well known since the beginning of the twentieth century, it remains to explore the mechanisms underlying the development of this chronic disease. Moreover, the recent researches have mostly focused on mechanisms of protection mediated by CD81 T cells and definition of candidates for vaccination. Due to the restrictive rules of ethical approaches in humans, we will discuss the validity of the mouse model to learn about the pathological consequences of host-immune response to T. cruzi. |



